Press releases
- Charles River Laboratories Announces First-Quarter 2024 Results
- Charles River Launches Viral Vector Reference Materials to Streamline the Transition to GMP
- Charles River Laboratories Achieves 100% Renewable Electricity Usage Globally
- Charles River Laboratories Launches Alternative Methods Advancement Project to Reduce Reliance on Animal Testing
- Charles River Laboratories Schedules First-Quarter 2024 Earnings Release and Conference Call
- Charles River and Deciphex Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic Pathology
- Charles River Announces Rare Disease Gene Therapy Collaboration with Axovia Therapeutics
- Charles River to Perform Plasmid Production for Ship of Theseus
- Charles River Laboratories Showcases Technology-Driven Capabilities at AACR 2024
- Charles River Laboratories Publishes 2023 Corporate Citizenship Report
More ▼
Key statistics
On Friday, Charles River Laboratories International Inc (RV6:MUN) closed at 215.00, -14.41% below its 52-week high of 251.20, set on Mar 25, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 215.00 |
---|---|
High | 215.00 |
Low | 215.00 |
Bid | 211.30 |
Offer | 212.60 |
Previous close | 219.20 |
Average volume | 15.33 |
---|---|
Shares outstanding | 51.51m |
Free float | 50.58m |
P/E (TTM) | 31.85 |
Market cap | 11.85bn USD |
EPS (TTM) | 7.22 USD |
Data delayed at least 15 minutes, as of May 10 2024 07:03 BST.
More ▼